Contraceptive efficacy of oral contraceptives under real life conditions: The impact of a 24-day regimen on contraceptive effectiveness

被引：0
|
作者：
Dinger, Juergen [1 ]
Assmann, Anita [1 ]
Altmann, Mathias [1 ]
机构：
[1] ZEG Ctr Epidemiol & Hlth Res, Berlin, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
236
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 36 条
  • [21] The impact of altering the hormone free interval on bleeding patterns in users of a 91-day extended regimen oral contraceptive
    Kauntiz, A. M.
    Zeape, K. Z.
    Portman, D.
    Hait, H.
    CONTRACEPTION, 2007, 76 (02) : 157 - 157
  • [22] The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol
    Kroll, Robin
    Reape, Kathleen Z.
    Margolis, Marya
    CONTRACEPTION, 2010, 81 (01) : 41 - 48
  • [23] Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis of four open-label studies
    Anttila, Leena
    Bachmann, Gloria
    Hernadi, Laszlo
    Kunz, Michael
    Marr, Joachim
    Klipping, Christine
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 155 (02) : 180 - 182
  • [24] A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg
    Mabrouk, Mohamed
    Solfrini, Serena
    Frasca, Clarissa
    Del Forno, Simona
    Montanari, Giulia
    Ferrini, Giulia
    Paradisi, Roberto
    Seracchioli, Renato
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (06) : 451 - 454
  • [25] IMPACT OF BODY WEIGHT ON OBSERVED PREGNANCY RATES WITH A LOW-DOSE ESTROGEN, 91-DAY EXTENDED REGIMEN ORAL CONTRACEPTIVE
    Reape, K.
    Shu, H.
    CONTRACEPTION, 2009, 80 (02) : 196 - 197
  • [26] Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen
    Brucker, Cosima
    Hedon, Bernard
    The, Hok Sien
    Hoeschen, Kornelia
    Binder, Natascha
    Christoph, Annette
    CONTRACEPTION, 2010, 81 (06) : 501 - 509
  • [27] Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women
    Nappi, Rossella E.
    Paoletti, Anna Maria
    Volpe, Annibale
    Chiovato, Luca
    Howard, Brandon
    Weiss, Herman
    Ricciotti, Nancy
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2014, 19 (04): : 285 - 294
  • [28] Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive
    Westhoff, Carolyn L.
    Hait, Howard I.
    Reape, Kathleen Z.
    CONTRACEPTION, 2012, 85 (03) : 235 - 239
  • [29] NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study
    von Stockum, Sophia
    Bauerfeind, Anja
    Becker, Kerstin
    Franke, Christian
    Fruzzetti, Franca
    Calaf, Joaquim
    Keck, Christoph
    Heinemann, Klaas
    GYNECOLOGICAL ENDOCRINOLOGY, 2023, 39 (01)
  • [30] Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive
    Kaunitz, Andrew M.
    Portman, David J.
    Hait, Howard
    Reape, Kathleen Z.
    CONTRACEPTION, 2009, 79 (05) : 350 - 355
1234